Form 4: Pfizer Director Reports Phantom Stock Unit Transaction

Pfizer Inc. director Cyrus Taraporevala reported a transaction involving phantom stock units, settled in common stock.

Summary

• Cyrus Taraporevala, a Director at Pfizer Inc., reported a transaction on June 26, 2026.
• The transaction involved the acquisition of 1,543.845 phantom stock units.
• These units represent deferred director's compensation, including dividend equivalents.
• The phantom stock units are settled in cash or common stock upon the director's retirement from the Board.
• The reported value of the acquired units was $24.29 per unit, totaling $36,941.287.
• The securities are beneficially owned directly by Mr. Taraporevala.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine compensation-related transaction for a director and does not indicate significant positive or negative developments for the company.

Positives

• Director compensation plan in place, offering deferred compensation and dividend equivalents.
• Phantom stock units provide flexibility for settlement in cash or common stock upon retirement.
• The transaction indicates continued engagement and compensation for a key board member.

Future Outlook

The phantom stock units are settled in cash or common stock at the director's election following retirement from the Board of Directors, indicating a future settlement event.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the holdings and activities of company directors and officers. This specific filing details a common form of executive compensation in the pharmaceutical industry.

Stakeholder Impact

• Shareholders: Increased transparency into director compensation and potential future share issuance if units are settled in stock.
• Employees: Indirectly, this filing is part of the overall corporate governance framework that impacts employee trust and company reputation.
• Management: Reinforces the compensation structure for board members.

Next Steps

• Settlement of phantom stock units in cash or common stock upon the reporting person's retirement from the Board of Directors.

Key Dates

Keywords

Pfizer Inc., PFE, Form 4, Director, Phantom Stock Units, Deferred Compensation, Beneficial Ownership, SEC Filing